FRANK BOHLINGER: Open Payments
NPI 1144485780 · HUNTSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,328 in 80 payments from 17 companies in 2025. Trend: 2023 $1,638 · 2024 $1,840 · 2025 $1,328
Food & beverage: $1,328
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 21 | $275 |
| Amgen Inc. | 12 | $171 |
| Merck Sharp & Dohme LLC | 5 | $133 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 7 | $123 |
| PFIZER INC. | 7 | $121 |
| Esperion Therapeutics, Inc. | 5 | $89 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $85 |
| E.R. Squibb & Sons, L.L.C. | 4 | $81 |
| Novo Nordisk Inc | 4 | $65 |
| Boston Scientific Corporation | 2 | $37 |
Products named: LEQVIO, Repatha, VERQUVO, ELIQUIS, LifeVest, NEXLETOL, JARDIANCE, Wegovy.
Industry payments across AL — which companies pay providers there.
